Entrada Therapeutics, Inc.
TRDANasdaqCIK 1689375HealthcareFiscal year ends Dec 31
Reports and events: 86 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1411:52 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-26-000057 |
| 2026-09-1020:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001231919-26-001160 |
| 2026-08-0511:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001689375-26-000054 |
| 2026-08-0511:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-26-000052 |
| 2026-06-1020:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072326 |
| 2026-05-1922:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-063325 |
| 2026-05-0711:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001689375-26-000028 |
| 2026-05-0711:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689375-26-000027 |
| 2026-04-2412:30 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001689375-26-000021 |
| 2026-02-2612:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001689375-26-000011 |
| 2026-02-2612:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-26-000009 |
| 2026-01-0812:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0001689375-26-000003 |
| 2025-11-1821:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001674324-25-000005 |
| 2025-11-0612:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001689375-25-000050 |
| 2025-11-0612:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-25-000049 |
| 2025-08-0611:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001689375-25-000043 |
| 2025-08-0611:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-25-000041 |
| 2025-06-1120:08 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-058536 |
| 2025-06-0311:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689375-25-000027 |
| 2025-05-0811:09 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001689375-25-000024 |
| 2025-05-0811:03 ET | 8-K | 2.02 Results of operations | 0001689375-25-000022 |
| 2025-04-2920:05 ET | 8-K | 2.05 Exit or disposal costs | 0001104659-25-041204 |
| 2025-04-2511:00 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001104659-25-039000 |
| 2025-03-2411:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-25-000018 |
| 2025-02-2712:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001689375-25-000011 |
| 2025-02-2712:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-25-000009 |
| 2025-02-2412:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-25-000004 |
| 2025-02-0312:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-25-000002 |
| 2025-01-1521:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-003755 |
| 2024-11-0512:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001689375-24-000063 |
| 2024-11-0512:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000061 |
| 2024-08-1311:14 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001689375-24-000047 |
| 2024-08-1311:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000045 |
| 2024-06-2620:54 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-075206 |
| 2024-06-2411:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-074130 |
| 2024-06-2410:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-074078 |
| 2024-06-1320:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-071249 |
| 2024-05-0711:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001689375-24-000027 |
| 2024-05-0711:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000025 |
| 2024-04-2913:11 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001104659-24-053564 |
| 2024-03-1311:24 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001689375-24-000016 |
| 2024-03-1311:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000014 |
| 2024-01-0312:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-000571 |
| 2023-12-0612:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-123805 |
| 2023-11-2212:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-120557 |
| 2023-11-0712:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001689375-23-000074 |
| 2023-11-0712:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-23-000072 |
| 2023-11-0111:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-113138 |
| 2023-09-2920:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-105351 |
| 2023-09-2111:09 ET | 8-K | 8.01 Other events | 0001689375-23-000068 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.